Home
Live Updates
Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33.86% : comparemela.com
Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33.86%
ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.
Related Keywords
United States ,
Hyderabad ,
Andhra Pradesh ,
India ,
Mumbai ,
Maharashtra ,
American ,
Satyanarayana Chava ,
Neha Myneni ,
Rahul Purwar ,
Immunoadoptive Cell Therapy Private ,
Laurus Lab ,
Indian Council Of Medical Research ,
American Society Of Hematology ,
Laurus Labs ,
Immunoadoptive Cell Therapy Private Limited ,
Gene Therapy ,
Navi Mumbai ,
Tata Memorial ,
American Society ,
Indian Patients ,
Indian Council ,
Pharma Analyst ,
Aurus Labs Invest ,
comparemela.com © 2020. All Rights Reserved.